Form 4: ADMA Biologics COO Reports Tax Withholding Share Transaction
SEC Form 4 Filing
Kaitlin M. Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On February 25, 2025, Kaitlin M. Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, had 1,855 shares of common stock withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
- This was not an open market sale.
- Following the transaction, Kestenberg-Messina beneficially owns 522,161 shares of ADMA Biologics common stock.
- This total includes unvested RSUs granted on various dates and shares of common stock owned by the reporting person.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of transaction: Shares withheld for tax obligations. |
| 02/27/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.